{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:52:22Z","timestamp":1771462342673,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jdermsci.2016.02.001","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T08:00:42Z","timestamp":1454918442000},"page":"137-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists"],"prefix":"10.1016","volume":"82","author":[{"given":"Mayumi","family":"Hatakeyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Washio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Nishigori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.02.001_bib0005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11882-009-0038-x","article-title":"New concepts of hive formation in cholinergic urticaria","volume":"9","author":"Horikawa","year":"2009","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.jdermsci.2016.02.001_bib0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2332\/allergolint.10-OA-0269","article-title":"Rapid desensitization with autologous sweat in cholinergic urticaria","volume":"60","author":"Kozaru","year":"2011","journal-title":"Allergol. Int. Off. Jap. Soc. Allergol."},{"key":"10.1016\/j.jdermsci.2016.02.001_bib0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2133.1987.tb05877.x","article-title":"Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria","volume":"116","author":"Wong","year":"1987","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.02.001_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7205\/MILMED.173.2.217","article-title":"Successful treatment of disabling cholinergic urticaria","volume":"173","author":"Feinberg","year":"2008","journal-title":"Mil. Med."},{"issue":"850","key":"10.1016\/j.jdermsci.2016.02.001_bib0025","article-title":"Cholinergic urticaria successfully treated with scopolamine butylbromide","volume":"42","author":"Tsunemi","year":"2003","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.02.001_bib0030","article-title":"Failure of omalizumab in cholinergic urticaria","author":"Sabroe","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.02.001_bib0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2007.01591.x","article-title":"Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy","volume":"63","author":"Metz","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jdermsci.2016.02.001_bib0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/WOX.0b013e31825a72fc","article-title":"Evaluation of different combined regimens in the treatment of cholinergic urticaria","volume":"5","author":"Alsamarai","year":"2012","journal-title":"World Allergy Org. J."},{"key":"10.1016\/j.jdermsci.2016.02.001_bib0045","doi-asserted-by":"crossref","first-page":"L159","DOI":"10.1016\/0024-3205(94)00553-2","article-title":"Effects of the new histamine H2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage","volume":"54","author":"Ichikawa","year":"1994","journal-title":"Life Sci."},{"issue":"46","key":"10.1016\/j.jdermsci.2016.02.001_bib0050","article-title":"Japanese version of the dermatology life quality index: validity and reliability in patients with acne","volume":"4","author":"Takahashi","year":"2006","journal-title":"Health Qual. Life Outcomes"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116300135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116300135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T16:56:03Z","timestamp":1537030563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116300135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0923181116300135"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.02.001","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}